Still, eight of 10 had the Tdap vaccine for tetanus, diphtheria and pertussis, while 63 percent had the MCV4 meningococcal vaccine.
FORBES: Merck & Its HPV Vaccine: Sales & Skepticism Are Both Up
应用推荐
模块上移
模块下移
不移动